Danish pharmaceutical giant Novo Nordisk announced Thursday that cybercriminals successfully breached multiple internal computer networks at the company.
The drugmaker has enlisted outside cybersecurity specialists to help investigate the breach and has notified appropriate government agencies about the incident.
As a precautionary measure, Novo Nordisk has shut down several internal computer networks temporarily while working to restore the compromised systems using secure protocols.
“While our investigation and response are ongoing, we have discovered that certain non-public data, including personal data, were copied externally without authorisation. We are informing the impacted parties as appropriate,” the Danish drugmaker said.
The pharmaceutical company emphasized that its primary business functions continue operating normally despite the cybersecurity incident.
